{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:17:27Z","timestamp":1784931447554,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671800"],"award-info":[{"award-number":["81671800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Municipal Natural Science Foundation","award":["7172204"],"award-info":[{"award-number":["7172204"]}]},{"name":"Translational Medicine Project of PLA General Hospital","award":["2017TM-013"],"award-info":[{"award-number":["2017TM-013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>This study investigates the effectiveness of local application of doxorubicin(Dox)-loaded, polydopamine (PDA)- coated single crystal hematite (\u03b1- Fe<jats:sub>2<\/jats:sub>O<jats:sub>3<\/jats:sub>) nanocubes (Fe<jats:sub>2<\/jats:sub>O<jats:sub>3<\/jats:sub>-PDA-Dox) and combretastatin A-4 phosphate disodium(CA4P)in treating hepatocellular carcinoma (HCC) in rats.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The magnetic characteristics and photothermal effects of the nanoparticles were determined in vitro<jats:italic>.<\/jats:italic> Tumor-bearing Sprague\u2013Dawley rats were divided into 3 groups of 8 according to treatment: controls, transarterial chemoembolization\u2013photothermal ablation (pTACE) (Lipidol+Fe<jats:sub>2<\/jats:sub>O<jats:sub>3<\/jats:sub>-PDA-Dox\u2009+\u2009NIR), and CA4P\u2009+\u2009pTACE (CA4P+ Lipidol+Fe<jats:sub>2<\/jats:sub>O<jats:sub>3<\/jats:sub>-PDA-Dox\u2009+\u2009NIR). Drugs were administered through the hepatic artery, and the tumors exposed to 808-nm near-infrared radiation. The Fe content of tumors was assessed using neutron activation analysis. Treatment effectiveness was assessed using heating curves, magnetic resonance imaging, pathology results, and immunohistochemical analysis.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean tumor Fe content was greater in rats treated with CA4P\u2009+\u2009pTACE (1\u2009h, 23.72\u2009\u00b1\u200912.45\u2009\u03bcg\/g; 24\u2009h, 14.61\u2009\u00b1\u20098.23\u2009\u03bcg\/g) than in those treated with pTACE alone (1\u2009h, 5.66\u2009\u00b1\u20094.29\u2009\u03bcg\/g; 24\u2009h, 2.76\u2009\u00b1\u20091.33\u2009\u03bcg\/g). The tumor T2 imaging signal was lower in rats treated with CA4P\u2009+\u2009pTACE. Following laser irradiation, the tumor temperature increased, with higher temperatures reached in the CA4P\u2009+\u2009pTACE group (62\u2009\u00b0C vs 55\u2009\u00b0C). Tumor cells exhibited necrosis, apoptosis, and proliferation inhibition, with greater effects in the CA4P\u2009+\u2009pTACE group. Transient liver and kidney toxicity were observed on day 3, with more severe effects after CA4P\u2009+\u2009pTACE.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Fe<jats:sub>2<\/jats:sub>O<jats:sub>3<\/jats:sub>-PDA-Dox nanoparticles are effective for TACE\u2013PTA. Pretreatment with CA4P increases nanoparticle uptake by tumors, increasing the treatment effectiveness without increasing hepatorenal toxicity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40644-019-0257-x","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T15:04:42Z","timestamp":1572879882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization\u2013photothermal ablation treatment of hepatocellular carcinoma in rats"],"prefix":"10.1186","volume":"19","author":[{"given":"Hongjun","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"issue":"4","key":"257_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","volume":"11","author":"M Omata","year":"2017","unstructured":"Omata M, Cheng AL, Kokudo N, et al. Asia\u2013Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update[J]. Hepatol Int. 2017;11(4):317\u201370.","journal-title":"Hepatol Int"},{"issue":"6","key":"257_CR2","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jamaoncol.2015.2189","volume":"1","author":"YR Huo","year":"2015","unstructured":"Huo YR, Eslick GD. Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: a systematic review and meta-analysis[J]. Jama Oncology. 2015;1(6):756.","journal-title":"Jama Oncology"},{"issue":"4","key":"257_CR3","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/j.1572-0241.2007.01712.x","volume":"103","author":"A Sergio","year":"2008","unstructured":"Sergio A, Cristofori C, Cardin R, et al. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness[J]. Am J Gastroenterol. 2008;103(4):914\u201321.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"257_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jhep.2011.12.022","volume":"57","author":"F Farinati","year":"2012","unstructured":"Farinati F, Giacomin A, Vanin V, et al. TACE treatment in hepatocellular carcinoma: what should we do now?[J]. J Hepatol. 2012;57(1):221\u20132.","journal-title":"J Hepatol"},{"issue":"1","key":"257_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/jbm.a.34680","volume":"102","author":"H Li","year":"2013","unstructured":"Li H, Bian S, Huang Y, et al. High drug loading pH-sensitive pullulan-DOX conjugate nanoparticles for hepatic targeting[J]. J Biomed Mater Res A. 2013;102(1):150\u20139.","journal-title":"J Biomed Mater Res A"},{"issue":"7","key":"257_CR6","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1039\/c2cs35031a","volume":"41","author":"A Taylor","year":"2012","unstructured":"Taylor A, Wilson KM, Murray P, et al. ChemInform abstract: long-term tracking of cells using inorganic nanoparticles as contrast agents: are we there yet?[J]. Chem Soc Rev. 2012;41(7):2707\u201317.","journal-title":"Chem Soc Rev"},{"issue":"24","key":"257_CR7","doi-asserted-by":"publisher","first-page":"20426","DOI":"10.1021\/acsami.7b04438","volume":"9","author":"L Dong","year":"2017","unstructured":"Dong L, Zhang P, Lei P, et al. PEGylated GdF3:Fe nanoparticles as multimodal T1\/T2-weighted MRI and X-ray CT imaging contrast agents[J]. ACS Appl Mater Interfaces. 2017;9(24):20426\u201334.","journal-title":"ACS Appl Mater Interfaces"},{"key":"257_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cplett.2016.12.019","volume":"668","author":"E Masoudipour","year":"2017","unstructured":"Masoudipour E, Kashanian S, Maleki N. A targeted drug delivery system based on dopamine functionalized nano graphene oxide[J]. Chem Phys Lett. 2017;668:56\u201363.","journal-title":"Chem Phys Lett"},{"issue":"1","key":"257_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12274-012-0275-5","volume":"6","author":"X Ruijun","year":"2013","unstructured":"Ruijun X. Bhirde, et al. hollow iron oxide nanoparticles as multidrug resistant drug delivery and imaging vehicles[J]. Nano Res. 2013;6(1):1\u20139.","journal-title":"Nano Res"},{"issue":"8\u201310","key":"257_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jnoncrysol.2006.12.083","volume":"353","author":"T L\u00f3pez","year":"2007","unstructured":"L\u00f3pez T, Quintana P, Mart\u00ednez JM, et al. Stabilization of dopamine in nanosilica sol\u2013gel matrix to be used as a controlled drug delivery system[J]. J Non-Cryst Solids. 2007;353(8\u201310):987\u20139.","journal-title":"J Non-Cryst Solids"},{"key":"257_CR11","first-page":"121","volume-title":"Dopamine-melanin colloidal Nanospheres for MRI-guided Photothermal therapy[M]\/\/multifunctional Nanoprobes","author":"Y Liu","year":"2018","unstructured":"Liu Y. Dopamine-melanin colloidal Nanospheres for MRI-guided Photothermal therapy[M]\/\/multifunctional Nanoprobes. Singapore: Springer; 2018. p. 121\u201351."},{"issue":"1\u20133","key":"257_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejphar.2012.08.023","volume":"695","author":"J Su","year":"2012","unstructured":"Su J, Laursen BE, Eskildsen-Helmond Y, et al. The vascular-disrupting agent, combretastatin-A4-phosphate, enhances neurogenic vasoconstriction in rat small arteries[J]. Eur J Pharmacol. 2012;695(1\u20133):104\u201311.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"257_CR13","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ijrobp.2010.12.028","volume":"80","author":"D Zhao","year":"2011","unstructured":"Zhao D, Chang CH, Kim JG, et al. In vivo near-infrared spectroscopy and magnetic resonance imaging monitoring of tumor response to Combretastatin A-4-phosphate correlated with therapeutic outcome[J]. Int J Radiat Oncol Biol Phys. 2011;80(2):574\u201381.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"257_CR14","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1021\/cr030063a","volume":"105","author":"C Burda","year":"2005","unstructured":"Burda C, Chen X, Narayanan R, et al. Chemistry and properties of nanocrystals of different shapes[J]. Chem Rev. 2005;105(4):1025\u2013102.","journal-title":"Chem Rev"},{"issue":"3","key":"257_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3747\/co.21.1829","volume":"21","author":"N. Molla","year":"2014","unstructured":"Molla N , Almenieir N , Simoneau E , et al. The role of interventional radiology in the management of hepatocellular carcinoma[J]. Current Oncology, 2014, 21(3):480-.","journal-title":"Current Oncology"},{"issue":"8","key":"257_CR16","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.3748\/wjg.v21.i8.2395","volume":"21","author":"DS Song","year":"2015","unstructured":"Song DS, Nam SW, Si HB, et al. Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma[J]. World J Gastroenterol. 2015;21(8):2395\u2013404.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"257_CR17","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1021\/acsami.6b11579","volume":"9","author":"W Cai","year":"2017","unstructured":"Cai W, Gao H, Chu C, et al. Engineering photo-Theranostic Nanoscale metal-organic frameworks for multi-modal imaging-guided Cancer therapy[J]. ACS Appl Mater Interfaces. 2017;9(3):2040\u201351.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"56","key":"257_CR18","doi-asserted-by":"publisher","first-page":"11194","DOI":"10.1039\/C5CC02536B","volume":"51","author":"ADA Zottis","year":"2015","unstructured":"Zottis ADA, Beltrame JM, Lara LRS, et al. Pheomelanin-coated iron oxide magnetic nanoparticles: a promising candidate for negative T2 contrast enhancement in magnetic resonance imaging[J]. Chem Commun. 2015;51(56):11194\u20137.","journal-title":"Chem Commun"},{"issue":"2","key":"257_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1148\/radiol.2016152510","volume":"281","author":"Junjie Li","year":"2016","unstructured":"Li J, Zhou M, Liu F, et al. Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.[J]. Radiology, 2016, 281(2):152510.","journal-title":"Radiology"},{"issue":"4","key":"257_CR20","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1021\/acs.nanolett.6b00331","volume":"16","author":"Yue Yuan","year":"2016","unstructured":"Yuan Y, Ding Z, Qian J, et al. Casp3\/7-Instructed Intracellular Aggregation of Fe3O4 Nanoparticles Enhances T2 MR Imaging of Tumor Apoptosis[J]. Nano Lett. 2016:16(4).","journal-title":"Nano Letters"},{"issue":"9","key":"257_CR21","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/adma.201204683","volume":"25","author":"Y Liu","year":"2013","unstructured":"Liu Y, Ai K, Liu J, et al. Dopamine-melanin colloidal nanospheres: an efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy.[J]. Adv Mater. 2013;25(9):1353\u20139.","journal-title":"Adv Mater"},{"key":"257_CR22","doi-asserted-by":"crossref","unstructured":"Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor[J]. Acta Biomater, 2017, 47:124\u2013134.","DOI":"10.1016\/j.actbio.2016.10.010"},{"issue":"12","key":"257_CR23","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1177\/000313481708301221","volume":"83","author":"S Thakur","year":"2017","unstructured":"Thakur S, Lavito S, Grobner E, et al. Radiofrequency thermal ablation heat energy transfer in an ex-vivo model[J]. Am Surg. 2017;83(12):1373\u201380.","journal-title":"Am Surg"},{"issue":"42","key":"257_CR24","doi-asserted-by":"publisher","first-page":"33586","DOI":"10.1039\/C5RA03302K","volume":"5","author":"P Das","year":"2015","unstructured":"Das P, Jana NR. Dopamine functionalized polymeric nanoparticle for targeted drug delivery[J]. RSC Adv. 2015;5(42):33586\u201394.","journal-title":"RSC Adv"},{"issue":"2","key":"257_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0009-9260(03)00316-7","volume":"59","author":"SC Yu","year":"2004","unstructured":"Yu SC, Yeung DT, So NM. Imaging features of hepatocellular carcinoma.[J]. Clin Radiol. 2004;59(2):145\u201356.","journal-title":"Clin Radiol"},{"key":"257_CR26","doi-asserted-by":"crossref","unstructured":"Berretta M, Rinaldi L, Di BF, et al. Angiogenesis inhibitors for the treatment of hepatocellular carcinoma[J]. Front Pharmacol. 2016;7.","DOI":"10.3389\/fphar.2016.00428"},{"issue":"1","key":"257_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S2468-1253(17)30324-2","volume":"3","author":"BC Odisio","year":"2018","unstructured":"Odisio BC, Kaseb AO. Anti-angiogenic therapy in the setting of TACE: an elusive synergy?[J]. Lancet Gastroenterology and Hepatology. 2018;3(1):5.","journal-title":"Lancet Gastroenterology and Hepatology"},{"key":"257_CR28","doi-asserted-by":"publisher","first-page":"28139","DOI":"10.1038\/srep28139","volume":"6","author":"M Su","year":"2016","unstructured":"Su M, Huang J, Liu S, et al. The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4[J]. Sci Rep. 2016;6:28139.","journal-title":"Sci Rep"},{"issue":"8","key":"257_CR29","first-page":"942","volume":"16","author":"A Siebert","year":"2016","unstructured":"Siebert A, Gensicka M, Cholewinski G, et al. Synthesis of combretastatin A-4 analogs and their biological activities[J]. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2016;16(8):942\u201360.","journal-title":"Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)"},{"issue":"7","key":"257_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1200\/JCO.2011.39.3934","volume":"30","author":"ES Wang","year":"2012","unstructured":"Wang ES, Pili R, Seshadri M. Modulation of chemotherapeutic efficacy by vascular disrupting agents: optimizing the sequence and schedule.[J]. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology. 2012;30(7):761\u20133.","journal-title":"Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology"},{"issue":"17","key":"257_CR31","first-page":"6413","volume":"61","author":"GM Tozer","year":"2001","unstructured":"Tozer GM, Prise VE, Wilson J, et al. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability[J]. Cancer Res. 2001;61(17):6413\u201322.","journal-title":"Cancer Res"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-019-0257-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40644-019-0257-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-019-0257-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:29:57Z","timestamp":1604363397000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-019-0257-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["257"],"URL":"https:\/\/doi.org\/10.1186\/s40644-019-0257-x","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"8 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted with the approval of the hospital review boards of the Chinese People\u2019s Liberation Army General Hospital and was performed according to the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from all of the patients for the TACE+RFA procedure. Additional informed consent was not required for this retrospective study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All study participants, or their legal guardian, written consent to publish individual person\u2019s data in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}